The White House claims that drug pricing deals with pharmaceutical companies could save the US economy $529 billion over ten years, sparking debate over transparency, actual patient savings, and whether price reductions are offset by rising profits and costs for uncovered drugs.
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 1 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
pharma profits rose amid administration's drug pricing initiatives
Trump's drugmaker deals may save economy $529B over 10 years, White House saysSocial-media signal on the same topic, drawn from the social lens. Engagement is likes + 2×shares + 3×replies, the same weighting used across the digest cards. View on /social →
Spotted something wrong on this page? Report a correction.
